Evidence map›Paper›PMID 40643261›Full record

ArticleJournal of clinical microbiology2025

Multicenter evaluation of blood culture contamination and blood cultures practices in US acute care hospitals: time for standardization.

Valeria Fabre, Yea-Jen Hsu, Karen C Carroll, Aaron M Milstone, Alejandra B Salinas, Lilian M Abbo, Chris Bower, Jennifer Berry, Sarah Boyd, Kathleen O Degnan and 39 more

Abstract readMulticenter Study
In one paragraph

Article in Journal of clinical microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Observational
  2. In-depth analysis of sampling practice and yield of blood cultures.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

49 authors.

Valeria FabreDepartment of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0001-7374-9678
Yea-Jen HsuDepartment of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Karen C CarrollDepartment of Pathology, Division of Medical Microbiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0001-8080-5391
Aaron M MilstoneDepartment of Pediatrics, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Alejandra B SalinasDepartment of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Lilian M AbboJackson Health System, Miami, Florida, USA.ORCID 0000-0002-2364-8358
Chris BowerDepartment of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia, USA.
Jennifer BerryDepartment of Infection Control, Sibley Memorial Hospital, D.C., USA.
Sarah BoydSaint Luke's (West Region) BJC Health System, Kansas City, Missouri, USA.
Kathleen O DegnanDepartment of Medicine, Division of Infectious Diseases, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Pragya DhaubhadelGeisinger, Danville, Pennsylvania, USA.
Daniel J DiekemaDepartment of Medicine, University of lowa Carver College of Medicine, Iowa City, lowa, USA.
Marci DressChristianaCare, Wilmington, Delaware, USA.
Baevin FeeserDivision of Infection Control/Hospital Epidemiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Mark FisherDepartment of Pathology and ARUP Laboratories, University of Utah School of Medicine, Salt Lake City, Utah, USA.
Cynthia FlynnChristianaCare, Wilmington, Delaware, USA.
Bradley A FordDepartment of Pathology, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA.
Erin B GettlerDivision of Infectious Diseases, Duke University, Durham, North Carolina, USA.
Laurel J GlasserDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Jessica Howard-AndersonDepartment of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia, USA.
J Kristie JohnsonDepartment of Pathology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Justin J KimDepartment of Medicine, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, USA.
Alyssa KubischtaSuburban Hospital, Bethesda, Maryland, USA.
Benjamin M LandrumHoward County General Hospital, Columbia, Maryland, USA.
Marvin MartinezBrown University Health, Providence, Rhode Island, USA.
Amy J MathersDivision of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia, USA.
Leonard MermelBrown University Health, Providence, Rhode Island, USA.
Rebekah W MoehringDivision of Infectious Diseases, Duke University, Durham, North Carolina, USA.
John C O'HoroDivision of Public Health, Infectious Diseases and Occupational Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Dana E PepeDivision of Infection Control/Hospital Epidemiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
S Sonia QasbaSuburban Hospital, Bethesda, Maryland, USA.
Barry RittmannDepartment of Medicine, Virginia Commonwealth University, Richmond, Virginia, USA.
Evan D RobinsonDivision of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia, USA.
Guillermo Rodríguez-NavaDivision of Infectious Diseases, Stanford University School of Medicine, Stanford, California, USA.
Rossana RosaJackson Health System, Miami, Florida, USA.
Jonathan H RyderDepartment of Internal Medicine, Division of Infectious Diseases, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Jorge L SalinasDivision of Infectious Diseases, Stanford University School of Medicine, Stanford, California, USA.
Aditya ShahDivision of Public Health, Infectious Diseases and Occupational Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Gregory M SchrankDepartment of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Mark ShellyGeisinger, Danville, Pennsylvania, USA.
Emily S SpivakDivision of Infectious Diseases, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA.
Kathleen O StewartDepartment of Quality Assurance and Safety, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, USA.
Thomas R TalbotDepartment of Medicine, Division of Infectious Diseases, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Trevor C Van SchooneveldDepartment of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Anastasia WasylyshynDepartment of Medicine, Division of Infectious Disease, University of Michigan Health, Ann Arbor, Michigan, USA.
Avinash GadalaHospital Epidemiology and Infection Control, Johns Hopkins Health System, Baltimore, Maryland, USA.
Zunaira VirkDepartment of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Sara E CosgroveDepartment of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Funding

CDC HHS #1 U54 CK000617-01NCEZID CDC HHS U54 CK000617
6 · The paper itself

Abstract

Clinical and Laboratory Standards Institute (CLSI) recommends a blood culture contamination (BCC) threshold of <3%, with ≤1% considered optimal. However, there is not a standardized definition of BCC, and the effect of multiple definitions on BCC rates or what definitions laboratories use remain unknown. We surveyed 52 hospitals and analyzed 362,078 blood cultures (BCx) collected 1 September 2019 to 31 August 2021 from 62 intensive care units (ICUs) and 231 wards from 48 of these hospitals. We calculated and compared BCC rates using the College of American Pathologists (CAP) or CLSI criteria (both utilize a limited number of skin commensals to define BCC) and the comprehensive National Healthcare Safety Network (NHSN) commensal list. We characterized factors associated with BCC and related outcomes (central-line associated bloodstream infection [CLABSI] and vancomycin use). BCC, BCx positivity, and single BCx rates were monitored by 100%, 39%, and 21% of hospitals, respectively. Hospitals used CAP (65%), CLSI (17%), and NHSN (17%) criteria to define BCC. Mean BCC rate by CAP (CAP-BCC) was 1.38% for ICUs and 0.96% for wards. BCC rates remained similar by CLSI criteria but increased when using NHSN list. Sharing BCC data outside of the laboratory, measuring additional BCx quality indicators, and limiting central catheter-drawn BCx were associated with lower BCC rates. BCC was associated with higher CLABSI rates in ICUs. This study demonstrated variability in laboratory practices and opportunities to optimize BCx stewardship.IMPORTANCEBlood culture contamination (BCC) is associated with patient harm and unnecessary use of healthcare resources. BCC thresholds have been established; however, multiple BCC definitions exist. There is limited data on how BCC rates differ depending on the BCC definition used, what definitions laboratories most commonly use, or their approach to other blood cultures (BCx) quality indicators such as single rates or BCx positivity. A cross-sectional multicenter survey and analysis of BCx data from intensive care unit and wards revealed that most laboratories did not track single BCx or BCx positivity rates and that there was variability in how BCC was defined. Additionally, BCC rates were influenced by the definition used. BCC was associated with increased central-line associated bloodstream infection rates.

Indexed as

Blood CultureHospitalsCatheter-Related InfectionsHumansIntensive Care UnitsUnited Statesbenchmarkblood culturecontamination

Identifiers

PMID40643261
PMCPMC12345234

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.